Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.

MLA

Fang, Leiming, et al. “Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.” Genes, vol. 13, no. 4, Apr. 2022, p. 654. EBSCOhost, https://doi.org/10.3390/genes13040654.

APA

Fang, L., Liu, Q., Cui, H., Zheng, Y., & Wu, C. (2022). Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers. Genes, 13(4), 654. https://doi.org/10.3390/genes13040654

Chicago

Fang, Leiming, Qi Liu, Hongtu Cui, Yunji Zheng, and Chengjun Wu. 2022. “Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.” Genes 13 (4): 654. doi:10.3390/genes13040654.